Finance

Lists
600479:SHA
ZhuZhou QianJin Pharmaceutical Co., Ltd
CN¥10.44
+1.95%
(+0.20) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600479...
Open
CN¥10.22
High
CN¥10.73
Low
CN¥10.06
Mkt. cap
5.14B
Avg. vol.
43.44M
Volume
21.35M
Dividend
3.54%
Quarterly dividend
CN¥0.09
Ex-dividend date
Jun 30, 2026
P/E ratio
14.20
52-wk high
CN¥15.25
52-wk low
CN¥9.20
EPS
CN¥0.74
Shares outstanding
418.51M
No. of employees
5K
Open
CN¥10.22
High
CN¥10.73
Low
CN¥10.06
Mkt. cap
5.14B
Avg. vol.
43.44M
Volume
21.35M
Dividend
3.54%
Quarterly dividend
CN¥0.09
Ex-dividend date
Jun 30, 2026
P/E ratio
14.20
52-wk high
CN¥15.25
52-wk low
CN¥9.20
EPS
CN¥0.74
Shares outstanding
418.51M
No. of employees
5K
News stories
From web sources and news partners
About ZhuZhou QianJin Pharmaceutical Co., Ltd
CEO-
Employees5.04K
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitecnqjyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
910.51M
970.27M
948.03M
922.39M
Cost of goods sold
500.94M
495.55M
470.07M
477.37M
Cost of revenue
500.94M
495.55M
470.07M
477.37M
Research and development expenses
40.70M
38.97M
51.26M
45.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
246.01M
338.40M
290.09M
308.93M
Operating expense
284.40M
391.73M
341.41M
352.03M
Total operating expenses
785.33M
887.28M
811.48M
829.40M
Operating income
125.18M
82.99M
136.56M
92.98M
Other non operating income
-49.38K
-1.87M
-4.00M
2.64M
EBT including unusual items
136.39M
96.56M
136.04M
106.39M
EBT excluding unusual items
131.92M
92.29M
135.19M
111.11M
Income tax expense
18.95M
12.36M
20.33M
18.88M
Effective tax rate
13.89%
12.81%
14.94%
17.75%
Other operating expenses
8.06M
4.60M
7.74M
-538.52K
Net income
98.94M
75.00M
105.84M
76.86M
Net profit margin
10.87%
7.73%
11.16%
8.33%
Earnings per share
-
-
-
-
Interest and investment income
6.79M
11.18M
2.63M
15.48M
Interest expense
-4.13K
-
-
-
Net interest expenses
6.79M
11.18M
2.63M
15.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
144.29M
102.10M
158.92M
112.10M
Gain or loss from assets sale
-1.88M
-
-706.54K
706.54K
Upcoming events
AI content may include mistakes. Learn more
Google apps